(20) Cholinesterase Inhibitors & NMDA Receptor Antagonists

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/13

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 1:23 AM on 10/4/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

14 Terms

1
New cards

Alzheimer’s:

  • Loss of cholinergic pathways → ↓ acetylcholine

    • ACh is important for memory/mood

  • Glutamate/NMDA receptor

    • Glutamate = excitatory neurotransmitter important for learning + memory

    • NMDA receptor = type of glutamate receptor

    • Normal NMDA activation → important for synaptic plasticity + neuron survival

    • Dysregulated glutamate/NMDA signaling → neuronal injury/excitotoxicity


2
New cards

Alzheimer’s diagnosis

Impairment in 2 of these:

  • Memory

  • Communication/language

  • Focus/attention

  • Reasoning/judgment


3
New cards

Alzheimer’s Pathology

Plaques + tangles

4
New cards

Alzheimer’s Cure

No cure. Treatment is aimed at slowing/helping symptoms rather than curing Alzheimer’s.

5
New cards

Alzheimer drugs

Drug

Class / structure to recognize

Main action

Donepezil

Benzylpiperidine

AChE inhibitor

Rivastigmine

Aryl/phenyl carbamate

AChE inhibitor

Galantamine

Benzazepine

AChE inhibitor

Memantine

Adamantane cage + primary amine + essential 2 methyl

NMDA antagonist


6
New cards

Why AChE inhibitors work

  • Normally:

    • Acetylcholinesterase breaks down ACh

  • Drug: AChE inhibitor

    • → ↓ ACh breakdown

    • → ↑ ACh stays around in CNS

    • → helps cognitive function

  • Important:

    • AChE = the esterase we particularly want to inhibit in the CNS.


7
New cards

DONEPEZIL

  • Benzylpiperidine

  • 6-O-desmethyl ACTIVE metabolite

    • long DOA/once daily

  • Higher affinity for AChE

  • Greater selectivity for the brain

  • Can cause sleep disturbances

    • may be taken in the morning

  • Metabolism: CYP2D6 + CYP3A4


8
New cards

RIVASTIGMINE

  • PHENYL/ARYL CARBAMATE

    • → pseudo-irreversible inhibition

    • → DOA (because of inhibition and NOT active metabolte) + delayed onset


9
New cards

GALANTAMINE

  • BENZAZEPINE

  • essential OH + tertiary amine

    • OH is essential for enzyme binding

    • Modifying the structure → ↓ activity

  • Metabolism

    • Extensive metabolism - CYP2D6 + CYP3A4

    • Metabolites are inactive

    • Some drug is excreted unchanged

  • Used for mild–moderate Alzheimer's


10
New cards

MEMANTINE

  • Adamantane cage + primary amine + 2 essential methyl

  • Can be combined with donepezil

    • combination = Namzaric

  • Used for moderate–severe AD


11
New cards

DONEPEZIL - draw


12
New cards

RIVASTIGMINE - draw


13
New cards

GALANTAMINE - draw


14
New cards

MEMANTINE - draw